Macrocyclization of Quinazoline-Based EGFR Inhibitors Leads to Exclusive Mutant Selectivity for EGFR L858R and Del19
Jennifer Alisa Amrhein(Goethe University Frankfurt), Thomas Hanke(Goethe University Frankfurt)
Cited by 29
Related Papers
Back-Pocket Optimization of 2-Aminopyrimidine-Based Macrocycles Leads to Potent EPHA2/GAK Kinase Inhibitors
|Journal of Medicinal Chemistry|2024|13
Strontium substitution of gelatin modified calcium hydrogen phosphates as porous hard tissue substitutes
|Journal of Biomedical Materials Research Part A|2020|9
Discovery of 3-Amino-1H-pyrazole-Based Kinase Inhibitors to Illuminate the Understudied PCTAIRE Family
|International Journal of Molecular Sciences|2022|9
Back-pocket optimization of 2-aminopyrimidine-based macrocycles leads to potent dual EPHA2/GAK kinase inhibitors with antiviral activity
|bioRxiv (Cold Spring Harbor Laboratory)|2024|1